Development of visible-light-activatable photocaged PROTACs

Weizhi Weng1, Gang Xue1, Zhengying Pan1

  • 1State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School, Peking University, Shenzhen, 518055, China.

Insights

Researchers developed visible-light-activatable photocaged proteolysis-targeting chimeras (PROTACs) for precise control over protein degradation. This advancement overcomes limitations of ultraviolet light, enabling new applications in biological research and therapeutics.

Area of Science:

  • Chemical biology
  • Molecular pharmacology
  • Drug discovery

Background:

  • Photocaged proteolysis-targeting chimeras (PROTACs) offer light-inducible protein degradation.
  • Current limitations include poor UV light penetration and lack of diverse caging positions.
  • Visible-light activation is desirable for deeper tissue penetration and broader biological applications.

Purpose of the Study:

  • To develop and characterize visible-light-activatable photocaged PROTACs.
  • To investigate the impact of different photocaging positions on PROTAC activity.
  • To identify potent visible-light-controlled PROTACs for use in live cells.

Main Methods:

  • Synthesis of photocaged PROTACs utilizing photocaged groups with excitation wavelengths from 365 nm to 405 nm.
  • Modification of cereblon (CRBN) and Von Hippel-Lindau (VHL)-recruiting Brd4 degraders at various positions.
  • Evaluation of photocaged PROTAC activity and control in live-cell degradation assays.

Main Results:

  • Identified specific positions (A2, A4, B3) on PROTACs as most effective for activity regulation.
  • Developed potent visible-light-controlled PROTAC molecules (compounds 9-12 and 17).
  • Demonstrated effective protein degradation in live cells using visible light.

Conclusions:

  • Visible-light-activatable photocaged PROTACs represent a significant advancement over UV-light-dependent systems.
  • Strategic placement of photocaged groups is crucial for optimizing PROTAC function.
  • These novel PROTACs offer enhanced control for biological applications and therapeutic strategies.